Artikelen

Using disclosures to your advantage

Jul 14, 2021 | Tags: Octrooien , IP Insight

NFTs – a slam dunk or a sticky wicket for brand owners?

Jul 6, 2021 | Tags: Octrooien , Merken , IP Insight

Disclosures

Jul 5, 2021 | Tags: Octrooien , IP Insight

Covid vaccine patent waivers – the opinion of our vaccine IP specialist

May 6, 2021 | Tags: Octrooien , Biosciences , IP Insight

Key Defence Innovations of the last 100 years

Apr 21, 2021 | Tags: IP Insight , Engineering , Defence

Where to Obtain Patent Protection?

Mar 9, 2021 | Tags: Octrooien , IP Insight

Chemists are in the driving seat of electric vehicle development

Feb 25, 2021 | Tags: Octrooien , Energy and environment , Battery technology

International (Hague) Designs: Protection in the UK and EU after Brexit

Jan 26, 2021 | Tags: Modellen , IP Insight

Freedom to Operate – What does it mean and a look at some different approaches

Jan 25, 2021 | Tags: Octrooien , IP Insight

Medical inventions – a European perspective

Jan 19, 2021 | Tags: Octrooien , Biosciences , IP Insight

Expediting Patent Prosecution – Use of International Examination

Nov 24, 2020 | Tags: Octrooien , IP Insight

Videoconference Hearings at the EPO – A Game-Changing Announcement from the EPO

Nov 11, 2020 | Tags: Octrooien , IP Insight

New Year, new-look IP portfolio - EU Trade Mark and Design Registrations are changing

Oct 20, 2020 | Tags: Merken , IP Insight

TM: Totally Meaningless?!

Aug 11, 2020 | Tags: Merken , IP Insight

The Unitary Patent and Unified Patent Court system – an update

Jul 21, 2020 | Tags: Octrooien , IP Insight

No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

Jul 16, 2020 | Tags: Octrooien , Biosciences , IP Insight